Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
December 31, 2019 63.09M
September 30, 2019 74.46M
June 30, 2019 75.83M
March 31, 2019 75.40M
December 31, 2018 75.14M
September 30, 2018 72.18M
June 30, 2018 71.09M
March 31, 2018 72.80M
December 31, 2017 139.68M
September 30, 2017 129.48M
June 30, 2017 126.43M
March 31, 2017 118.64M
December 31, 2016 111.17M
September 30, 2016 117.62M
June 30, 2016 117.19M
March 31, 2016 113.20M
December 31, 2015 110.88M
September 30, 2015 111.27M
June 30, 2015 124.81M
March 31, 2015 122.04M
December 31, 2014 125.90M
September 30, 2014 116.40M
June 30, 2014 125.99M
March 31, 2014 124.45M
December 31, 2013 96.04M
Date Value
September 30, 2013 95.47M
June 30, 2013 93.10M
March 31, 2013 96.45M
December 31, 2012 96.04M
September 30, 2012 93.50M
June 30, 2012 81.66M
March 31, 2012 80.01M
December 31, 2011 74.97M
September 30, 2011 78.02M
June 30, 2011 77.03M
March 31, 2011 73.11M
December 31, 2010 72.41M
September 30, 2010 64.82M
June 30, 2010 64.26M
March 31, 2010 63.14M
December 31, 2009 66.51M
September 30, 2009 63.23M
June 30, 2009 54.70M
March 31, 2009 42.28M
December 31, 2008 57.50M
September 30, 2008 65.50M
June 30, 2008 71.14M
March 31, 2008 70.07M
December 31, 2007 72.28M
September 30, 2007 65.53M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 66.63B
ANI Pharmaceuticals, Inc. 896.90M
Corcept Therapeutics, Inc. 182.93M
Veru, Inc. 8.651M
Avadel Pharmaceuticals Plc 101.22M